Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer.
Smaldone
M C
MC
Gingrich
J R
JR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009361:Neoplasm Invasiveness; D017211:Treatment Failure; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D007155:Immunologic Factors